Christine Pausch
Overview
Explore the profile of Christine Pausch including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
693
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Skowasch D, Pausch C, Huscher D, Pittrow D, Wede J, Kreimendahl F, et al.
ESC Heart Fail
. 2025 Mar;
PMID: 40037846
Aims: Pulmonary arterial hypertension (PAH) is often diagnosed in elderly patients with comorbidities. Although initial monotherapy is recommended for these patients, the value of combination therapy remains unclear. Here, we...
2.
McLaughlin V, Alsumali A, Liu R, Klok R, Martinez E, Nourhussein I, et al.
Adv Ther
. 2023 Oct;
41(1):130-151.
PMID: 37851297
Introduction: Pulmonary arterial hypertension (PAH) is a rare, progressive disease associated with significant morbidity and mortality. The phase 3 STELLAR trial tested sotatercept plus background therapy (BGT) versus placebo plus...
3.
Pausch C, Pittrow D, Hoeper M, Huscher D
Eur Respir J
. 2023 Oct;
62(5).
PMID: 37802633
No abstract available.
4.
Fasshauer M, Borte M, Bitzenhofer M, Pausch C, Pittrow D, Park M, et al.
Adv Ther
. 2023 Sep;
40(12):5168-5187.
PMID: 37751025
Introduction: The CORE study aimed to provide a detailed understanding of real-world immune globulin subcutaneous (human) 20% solution (Ig20Gly) utilization in patients with primary immunodeficiency diseases (PIDs) in Germany and...
5.
Distler O, Ofner C, Huscher D, Jordan S, Ulrich S, Stahler G, et al.
Rheumatology (Oxford)
. 2023 Jul;
63(4):1139-1146.
PMID: 37462520
Objectives: Pulmonary arterial hypertension (PAH) occurs in various connective tissue diseases (CTDs). We sought to assess contemporary treatment patterns and survival of patients with various forms of CTD-PAH. Methods: We...
6.
Schnabel D, Kreitschmann-Andermahr I, Strasburger C, Pittrow D, Pausch C, Woelfle J
Orphanet J Rare Dis
. 2023 May;
18(1):112.
PMID: 37165422
Background: Somatropin treatment is indicated in a variety of disorders including growth hormone (GH) deficiency, Prader-Willi and Turner syndrome, chronic renal insufficiency and others. To date, almost all studies have...
7.
Schmidt K, Milger K, Pausch C, Huscher D, Pittrow D, Grunig E, et al.
Eur Respir J
. 2023 Apr;
61(4).
PMID: 37105586
No abstract available.
8.
Rosenkranz S, Pausch C, Coghlan J, Huscher D, Pittrow D, Grunig E, et al.
J Heart Lung Transplant
. 2022 Nov;
42(1):102-114.
PMID: 36333206
Background: A diagnosis of idiopathic pulmonary arterial hypertension (IPAH) is frequently made in elderly patients who present with comorbidities, especially hypertension, coronary heart disease, diabetes mellitus, and obesity. It is...
9.
Hoeper M, Dwivedi K, Pausch C, Lewis R, Olsson K, Huscher D, et al.
Lancet Respir Med
. 2022 Jul;
10(10):937-948.
PMID: 35777416
Background: Among patients meeting diagnostic criteria for idiopathic pulmonary arterial hypertension (IPAH), there is an emerging lung phenotype characterised by a low diffusion capacity for carbon monoxide (DLCO) and a...
10.
Hoeper M, Pausch C, Olsson K, Huscher D, Pittrow D, Grunig E, et al.
J Heart Lung Transplant
. 2022 Apr;
41(7):971-981.
PMID: 35430147
Background: The prognostic value of improvement endpoints that have been used in clinical trials of treatments for pulmonary arterial hypertension (PAH) needs to be further investigated. Methods: Using the COMPERA...